Clinical Trial Update: ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox

View source ↗

Summary

ENTRUST is a five-year safety surveillance study evaluating deferasirox in children aged 2 to under 6 with transfusional iron overload related to anemia; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Anemia | Status: COMPLETED